Title : Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling.

Pub. Date : 2014 Jul

PMID : 24959268






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/beta-catenin signaling. Sulindac catenin beta 1 Homo sapiens
2 Further studies revealed that sulindac significantly induces c-Jun NH2-terminal kinase (JNK) 1 phosphorylation and inhibits beta-catenin at the transcriptional and post-transcriptional levels. Sulindac catenin beta 1 Homo sapiens
3 In conclusion, by targeting the JNK1/beta-catenin signaling pathway, sulindac may present a potential preventive or therapeutic agent for treatment of patients with prostate cancer. Sulindac catenin beta 1 Homo sapiens